Metastatic or Locally Advanced Unresectable Solid Tumors research hub
3 indexed studies · 2 currently recruiting
- recruitingHuman Pharmacology (Phase I)- First administration to humans
Tuvusertib (M1774) in Participants with Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301)
This early-stage clinical trial is testing a new cancer medicine called tuvusertib (M1774). It is for adults with advanced solid tumours that cannot be removed with surgery or have spread. Doctors want to find safe doses, learn about side effects, and see how the body handles the drug.
Spain - recruitingHuman Pharmacology (Phase I)- Other
Study of tuvusertib (M1774) in combination with DNA Damage Response Inhibitors or Immune Checkpoint Inhibitors
This study is looking at a new drug called tuvusertib (M1774) for people with advanced solid cancers that have spread or can't be removed by surgery. It's an early-stage study to see how the new drug works, if it's safe, and if it can be combined with other cancer treatments.
Spain - active not recruitingPHASE1
Tuvusertib (M1774) in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301)
This early-stage study is testing a new drug called Tuvusertib (M1774), alone or with another drug called niraparib, for people with advanced solid tumours that have spread or can't be removed by surgery. Doctors want to see if it's safe, how the body handles it, and if it shows any early signs of helping.
United States · China · Japan